• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌产生免疫反应性β-人绒毛膜促性腺激素的临床病理意义

Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer.

作者信息

Oliver R T, Stephenson C, Collino C E, Parkinson M C

机构信息

London Hospital Medical College, Whitechapel, UK.

出版信息

Mol Biother. 1988;1(1):43-5.

PMID:2477041
Abstract

Immunocytochemical screening of bladder tumors with an antibody to beta-human chorionic gonadotrophin (hCG) demonstrates a correlation with malignant behavior in that 0 of 20 G1M0, 5 of 20 G3M0, and 11 of 20 G2/3M + showed strong staining, while only 2/20 G3 Ca prostate and 0/18 renal cell carcinoma showed weak staining. There was a suggestion that hCG positive bladder cancer responded less well to chemotherapy (1 of 12 hCG positive and 6 of 13 hCG negative patients achieved a complete or partial response) and also patients whose tumors showed strong hCG staining did less well after radiotherapy, though paradoxically patients showing only occasional stained cells did better than patients whose tumor showed no staining. The possible significance of these observations in relation to recent observations on the mechanisms of trophoblast escape from immune surveillance is discussed.

摘要

用抗β-人绒毛膜促性腺激素(hCG)抗体对膀胱肿瘤进行免疫细胞化学筛查,结果显示其与恶性行为相关,具体如下:20例G1M0肿瘤中0例呈强染色,20例G3M0肿瘤中有5例呈强染色,20例G2/3M +肿瘤中有11例呈强染色,而20例G3期前列腺癌中只有2例呈弱染色,18例肾细胞癌中0例呈弱染色。有迹象表明,hCG阳性的膀胱癌对化疗反应较差(12例hCG阳性患者中有1例、13例hCG阴性患者中有6例实现了完全或部分缓解),而且肿瘤呈hCG强染色的患者放疗后效果也较差,不过矛盾的是,仅偶尔有染色细胞的患者比肿瘤无染色的患者效果更好。本文讨论了这些观察结果与近期关于滋养层细胞逃避免疫监视机制的观察结果可能具有的相关性。

相似文献

1
Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer.膀胱癌产生免疫反应性β-人绒毛膜促性腺激素的临床病理意义
Mol Biother. 1988;1(1):43-5.
2
Ectopic production of beta-subunit of human chorionic gonadotropin in malignant lymphoma.恶性淋巴瘤中人绒毛膜促性腺激素β亚基的异位产生
Zentralbl Pathol. 1991;137(5):402-4.
3
Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas.人绒毛膜促性腺激素β亚基基因在浅表性和浸润性膀胱癌中的表达
Cancer Res. 1995 Sep 1;55(17):3735-8.
4
Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.骨肉瘤中人绒毛膜促性腺激素β亚基的异位产生。
Arch Pathol Lab Med. 1989 Apr;113(4):416-9.
5
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.对人前列腺癌进行癌胚抗原、非特异性交叉反应抗原、β-绒毛膜促性腺激素和前列腺特异性抗原的免疫细胞化学评估。
Cancer Res. 1984 Jan;44(1):285-92.
6
Human chorionic gonadotropin beta-subunit synthesis by undifferentiated urothelial carcinoma with syncytiotrophoblastic differentiation.具有合体滋养层细胞分化的未分化尿路上皮癌合成人绒毛膜促性腺激素β亚基。
Arch Pathol Lab Med. 1994 Jul;118(7):715-7.
7
[Biologic behavior of human chorionic gonadotropin hormone (HCGH) in transitional cell carcinomas of the bladder].[人绒毛膜促性腺激素(HCGH)在膀胱移行细胞癌中的生物学行为]
Arch Esp Urol. 1993 Jul-Aug;46(6):469-72.
8
[A case of human chorionic gonadotropin-producing bladder cancer].
Hinyokika Kiyo. 2001 Jan;47(1):47-9.
9
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.基于人绒毛膜促性腺激素β亚基启动子的睾丸癌毒性基因治疗的开发。
Urology. 2004 Mar;63(3):613-8. doi: 10.1016/j.urology.2003.09.054.
10
Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.尿人绒毛膜促性腺激素游离β亚基和β核心片段:妇科癌症的一种新标志物。
Cancer Res. 1988 Mar 1;48(5):1356-60.

引用本文的文献

1
Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.用于测量膀胱癌患者异位人绒毛膜促性腺激素(hCG)分泌的不同hCG检测方法。
Br J Cancer. 1996 Oct;74(7):1081-4. doi: 10.1038/bjc.1996.493.
2
Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease.埃及患有良性和晚期恶性泌尿系统疾病患者的尿促性腺激素肽(UGP)
Br J Cancer. 1996 Jun;73(12):1486-90. doi: 10.1038/bjc.1996.281.
3
beta hCG as a prognostic marker in adenocarcinoma of the prostate.β人绒毛膜促性腺激素作为前列腺腺癌的预后标志物。
J Clin Pathol. 1996 Apr;49(4):329-32. doi: 10.1136/jcp.49.4.329.